Glenmark Pharmaceuticals has informed that the Board of Directors of the Company, at its meeting held today, Friday, 26th September, 2025, have approved the following agendas: The Board of Directors of the Company, has considered and approved the Interim Dividend of Rs 2.50 per equity shares on face value of Re 1 per equity shares for the Financial Year 2025-26 amounting to Rs 705.50 millions. As intimated earlier on 22nd September 2025, the record date for the purpose of payment of dividend shall be Friday, 3rd October, 2025, and the interim dividend will be paid within 30 days from the date of the declaration.
The above information is a part of company’s filings submitted to BSE.
